Sysmex Sverige
Menu

December - Emulsion PCR for highly sensitive detection of tumour mutations in peripheral blood

The BEAMing technology involves conversion of single DNA molecules to single magnetic beads, each containing thousands of copies of the sequence of the original DNA molecule. The number of variant DNA molecules in the population can be assessed by staining the beads with fluorescent probes and counting them by using flow cytometry. This way OncoBEAM® blood-based tests deliver a minimally invasive alternative for sensitive real-time molecular diagnostics to improve cancer characterisation and treatment.

Copyright © Sysmex Europe SE. All rights reserved.